Scinai Immunotherapeutics Shares Set to Reverse Split on Tuesday, May 21st (NASDAQ:SCNI)

Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI)’s stock is going to reverse split on the morning of Tuesday, May 21st. The 1-10 reverse split was announced on Tuesday, May 21st. The number of shares owned by shareholders will be adjusted after the market closes on Tuesday, May 21st.

Scinai Immunotherapeutics Price Performance

SCNI stock opened at $0.45 on Thursday. The company has a market capitalization of $841,313.00, a P/E ratio of -0.14 and a beta of 2.45. The business has a 50-day moving average price of $0.48 and a 200 day moving average price of $0.56. Scinai Immunotherapeutics has a 1-year low of $0.43 and a 1-year high of $2.27.

Scinai Immunotherapeutics Company Profile

Scinai Immunotherapeutics Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases, and other illnesses in Israel. It has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications.